• 1
    Nordberg GF, Nogawa K, Nordberg M, Friberg L. Cadmium. In: Nordberg GF, Fowler GF, Nordberg M, Friberg L, eds. Handbook on the Toxicology of Metals. Amsterdam: Elsevier, 2007; 44586.
  • 2
    Järup L, Akesson A. Current status of cadmium as an environmental health problem. Toxicol Appl Pharmacol 2009; 238: 2018.
  • 3
    Prozialeck WC, Edwards JR, Woods JM. The vascular endothelium as a target of cadmium toxicity. Minireview. Life Sci 2006; 79: 1493506.
  • 4
    Messner B, Bernhard D. Cadmium and cardiovascular diseases: cell biology, pathophysiology, and epidemiological relevance. Biometals 2010; 23: 81122.
  • 5
    Messner B, Knoflach M, Seubert A et al. Cadmium is a novel and independent risk factor for early atherosclerosis mechanisms and in vivo relevance. Arterioscler Thromb Vasc Biol 2009; 29: 13928.
  • 6
    Knoflach M, Messner B, Shen YH et al. Non-toxic cadmium concentrations induce vascular inflammation and promote atherosclerosis. Circ J 2011; 75: 24915.
  • 7
    Tellez-Plaza M, Navas-Acien A, Crainiceanu CM, Sharrett AR, Guallar E. Cadmium and peripheral arterial disease: gender differences in the 1999-2004 US National Health and Nutrition Examination Survey. Am J Epidemiol 2010; 172: 67181.
  • 8
    Peters JL, Perlstein TS, Perry MJ, McNeely E, Weuve J. Cadmium exposure in association with history of stroke and heart failure. Environ Res 2010; 110: 199206.
  • 9
    Menke A, Muntner P, Silbergeld EK, Platz EA, Guallar E. Cadmium levels in urine and mortality among U.S. adults. Environ Health Perspect 2009; 117: 1906.
  • 10
    Nawrot TS, Staessen JA, Roels HA et al. Cadmium exposure in the population: from health risks to strategies of prevention. Biometals 2010; 23: 76982.
  • 11
    Spence JD. Measurement of intima-media thickness vs. carotid plaque: uses in patient care, genetic research and evaluation of new therapies. Int J Stroke 2006; 1: 21621.
  • 12
    Mathiesen EB, Johnsen SH, Wilsgaard T, Bønaa KH, Løchen ML, Njølstad I. Carotid plaque area and intima-media thickness in prediction of first-ever ischemic stroke: a 10-year follow-up of 6584 men and women: the Tromsø Study. Stroke 2011; 42: 9728.
  • 13
    Brohall G, Behre CJ, Hulthe J, Wikstrand J, Fagerberg B. Prevalence of diabetes and impaired glucose tolerance in 64-year-old Swedish women: experiences of using repeated oral glucose tolerance tests. Diabetes Care 2006; 29: 3637.
  • 14
    Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 53953.
  • 15
    Stein JH, Korcarz CE, Hurst RT et al.; American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. J Am Soc Echocardiogr 2008; 21: 93111.
  • 16
    Wendelhag I, Liang Q, Gustavsson T, Wikstrand J. A new automated computerized analyzing system simplifies readings and reduces the variability in ultrasound measurement of intima-media thickness. Stroke 1997; 28: 2195200.
  • 17
    Prahl U, Holdfeldt P, Bergström G, Fagerberg B, Hulthe J, Gustavsson T. Percentage white: a new feature for ultrasound classification of plaque echogenicity in carotid artery atherosclerosis. Ultrasound Med Biol 2010; 36: 21826.
  • 18
    Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE; Lung Health Study Research Group. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 2005; 142: 2339.
  • 19
    Wannamethee SG, Shaper AG, Whincup PH, Walker M. Smoking cessation and the risk of stroke in middle-aged men. JAMA 1995; 274: 15560.
  • 20
    Kawachi I, Colditz GA, Stampfer MJ et al. Smoking cessation and decreased risk of stroke in women. JAMA 1993; 269: 2326.
  • 21
    Jiang CQ, Xu L, Lam TH, Lin JM, Cheng KK, Thomas GN. Smoking cessation and carotid atherosclerosis: the Guangzhou Biobank Cohort Study–CVD. J Epidemiol Community Health 2010; 64: 10049.
  • 22
    Abu-Hayyeh S, Sian M, Jones KG, Manuel A, Powell JT. Cadmium accumulation in aortas of smokers. Arterioscler Thromb Vasc Biol 2001; 21: 8637.
  • 23
    Brohall G, Odén A, Fagerberg B. Carotid artery intima-media thickness in patients with Type 2 diabetes mellitus and impaired glucose tolerance: a systematic review. Diabet Med 2006; 23: 60916.
  • 24
    Hu G; DECODE Study Group. Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes. Diabetologia 2003; 46: 60817.
  • 25
    Edwards JR, Prozialeck WC. Cadmium, diabetes and chronic kidney disease. Toxicol Appl Pharmacol 2009; 238: 28993.
  • 26
    Schmidt C, Hulthe J, Fagerberg B. Baseline ICAM-1 and VCAM-1 are increased in initially healthy middle-aged men who develop cardiovascular disease during 6.6 years of follow-up. Angiology 2009; 60: 10814.
  • 27
    Jeong EM, Moon CH, Kim CS et al. Cadmium stimulates the expression of ICAM-1 via NF-kappaB activation in cerebrovascular endothelial cells. Biochem Biophys Res Commun 2004; 320: 88792.
  • 28
    Moulis JM, Thévenod F. New perspectives in cadmium toxicity: an introduction. Biometals 2010; 23: 7638.
  • 29
    DECODE Study Group. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 2003; 26: 619.